Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million ...

Time magazine released its 'World's Top Universities of 2026' list, ranking 500 institutions globally. See which 14 ...

Dementia care isn't just about new drugs, said the author of a cost-effectiveness study comparing collaborative care, Leqembi ...

The new workflow was adapted from an enzymatic DNA tagging technology, DNA-TAG, previously developed in the Devaraj lab. In ...

Blockbuster movies are less likely to portray smokers than they have in the past, according to a new study. What's more, this decline in on-screen smoking may have occurred in tandem with a drop in ...

From television to artificial intelligence, new technologies have made it easier to fabricate the truth. The increasing use ...

Connor O'Brien, MD, provides an insight into awareness of dextrocardia and what clinicians can consider in the management of this population.

Explore how Epstein-Barr may link to multiple sclerosis, affecting nearly one million people in the United States.

Polaryx Therapeutics, Inc. (Nasdaq: PLYX) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, ...

Sports scientists are trying to figure out why female athletes are so prone to a specific type of knee injury.

Back in the day’ butts heads with ‘medicine today.’ A candid look at why physicians may never have the authority, respect, ...

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple ...